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Amino acid availability is sensed by GCN2 (general control
nonderepressible 2) and mechanistic target of rapamycin com-
plex 1 (mTORC1), but how these two sensors coordinate their
respective signal transduction events remains mysterious. In
this study we utilized mouse genetic models to investigate the
role of GCN2 in hepatic mTORC1 regulation upon amino acid
stress induced by a single injection of asparaginase. We found
that deletion of Gcn2 prevented hepatic phosphorylation of
eukaryotic initiation factor 2 to asparaginase and instead
unleashed mTORC1 activity. This change in intracellular sig-
naling occurredwithinminutes and resulted in increased 5-ter-
minal oligopyrimidine mRNA translation instead of activating
transcription factor 4 synthesis. Asparaginase also promoted
hepatic mRNA levels of several genes which function as
mTORC1 inhibitors, and these geneswere blunted or blocked in
the absence ofGcn2, but their timing could not explain the early
discordant effects in mTORC1 signaling. Preconditioning mice
with a chemical endoplasmic reticulum stress agent before amino
acid stress rescued normal mTORC1 repression in the liver of
Gcn2/micebut not in liverswith bothGcn2 and the endoplas-
mic reticulum stress kinase, Perk, deleted. Furthermore, treat-
ingwildtype andGcn2/micewith ISRIB, an inhibitor ofPERK
signaling, also failed to alter hepatic mTORC1 responses to
asparaginase, although administration of ISRIB alone had an
inhibitory GCN2-independent effect on mTORC1 activity.
Taken together, the data show that activating transcription fac-
tor 4 is not required, but eukaryotic initiation factor 2 phos-
phorylation is necessary to prevent mTORC1 activation during
amino acid stress.
A variety of cytoplasmic and proteotoxic stresses activates
the integrated stress response (ISR),2 a conserved survival strat-
egy in eukaryotes. In mammals, the ISR is triggered by a family
of kinases with a shared substrate; namely, the  subunit of
eukaryotic initiation factor 2 (eIF2). Phosphorylation of eIF2 at
serine 51 leads to global and gene-specific changes in transla-
tion that, depending on the timing and intensity of the stress,
direct the cell/tissue/organism toward adaptation or cell death
(1).
The translation factor eIF2 delivers initiator Met-tRNA and
GTP to the 40S ribosomal subunit during the initiation step and
is then released from the 80S monosome in the GDP-bound
form. Participation of eIF2 in a new round of translation initia-
tion requires GDP-GTP exchange by eIF2B, a guanine nucleo-
tide exchange factor for eIF2. Phosphorylation of eIF2 reduces
eIF2B activity (2), slowing reinitiation and resulting in prefer-
ential translation of mRNAs with specific inhibitory features.
The best characterizedmember of this group ofmRNAs is acti-
vating transcription factor 4 (ATF4), a basic leucine zipper
DNA-binding protein. Newly synthesized ATF4 regulates
transcription of genes containing cis-regulatory motifs called
CAAT enhancer-binding protein ATF response element (3).
The resulting transcriptional program alters cellular metabo-
lism to alleviate cytoplasmic and proteotoxic stress.
Another important signal transduction response to cellular
stress is the mechanistic target of rapamycin complex 1
(mTORC1) pathway. mTORC1 is a major positive regulator of
anabolic processes under conditions of nutrient and especially
amino acid sufficiency (4). Under nutrient-sufficient condi-
tions,mTORC1promotescellgrowthandproliferationbyphos-
phorylating multiple targets including ribosomal protein S6
kinase 1 (S6K1) and eIF4E-binding protein 1. A class ofmRNAs
specifically regulated bymTORC1 activity contains 5-terminal
oligopyrimidine (TOP) motifs (5). TOP mRNAs encode ribo-
somal proteins and other cellular machinery important for
translational capacity. Previous work by this lab shows hepatic
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TOP mRNA translation is preferentially inhibited by amino
acid deprivation in the liver of healthy rodents (6).
Inappropriate activation of mTORC1 during cytoplasmic or
proteotoxic stress has deleterious effects for both cells (7) and
organisms (8–12). Our labwas the first to identify the existence
of coordinated cross-talk between the ISR and mTORC1 path-
way in mammals following amino acid deprivation (10). Since
then, multiple labs have explored the basis for this bidirectional
relationship in animal tissues and in normal cells and cancer
cells (8, 13–21). Despite these efforts, the core factor(s) coordi-
nating ISR-mTORC1 communication during amino acid stress
remain mysterious. Furthermore, it is unclear whether the ISR
plays a role in regulating TOPmRNA translation during amino
acid stress.
To better understand when and how activation of the ISR
represses mTORC1 signaling during amino acid stress, we per-
formed time-course experiments inmice, analyzing the hepatic
response to amino acid depletion by asparaginase over a 24-h
time period. These experiments showed that deletion of the
eIF2 kinase GCN2 disallowed Atf4 translation and instead per-
mitted rapid activation of mTORC1 signaling and increased
TOP mRNA translation in response to asparaginase. We also
observed that mTORC1 activation following asparaginase
exposure in mice lacking Gcn2 preceded both translational
control of Atf4 gene expression and transcriptional control of
themTORC1modulators Sesn2 (sestrin 2), Redd1 (regulated in
development and DNA damage response), 4ebp1, and Trib3
(tribbles 3), indicating that the acute mTORC1 repressor was
not ATF4. Interestingly, mice lacking Perk in liver did not show
enhancedmTORC1 activity following injection of tunicamycin
(a pharmacological ER stress agent), signifying that communi-
cation between the ISR and mTORC1 is specific to amino acid
stress. Furthermore, pretreatment of Gcn2/mice with tuni-
camycin before asparaginase disallowed hepatic mTORC1
hyperactivation,whichwas restored by the loss of bothPerk and
Gcn2 in liver. Finally, pretreatment with ISRIB, a potent inhib-
itor of PERK signaling, did not alter eIF2 phosphorylation or
mTORC1 signaling in wildtype and Gcn2/ mice adminis-
tered asparaginase, but it did by itself reduce hepatic mTORC1
activity in bothwildtype andGcn2/mice. Taken together, we
conclude that eIF2 phosphorylation, not ATF4 synthesis, is
necessary for acute inhibition of hepatic mTORC1 and TOP
mRNA translation to amino acid stress inmice. Understanding
how healthy organisms respond and adapt to amino acid defi-
ciency at the molecular level may help in the development of
improved and targetedmeans to treat cancer and other chronic
diseases.
Results
Loss of Gcn2 quickly unleashes hepatic mTORC1 activity
during amino acid stress
To define the role of GCN2 in the regulation of hepatic
mTORC1 in response to amino acid stress in an in vivo setting,
we utilized asparaginase to activate hepatic GCN2 (Fig. 1A).
The kinetics of amino acid changes in the blood induced by
asparaginase injection were similar in wildtype and Gcn2/
mice (Table S2 and Figs. S1 and S2). Notably, asparagine con-
centrations were consistently reduced over time, whereas glu-
tamine concentrations were acutely reduced at 3 h after injec-
tion, which then recovered to serum levels in untreatedmice by
12 h (Fig. S1). Circulating levels of most other amino acids and
in particular the dietary essential amino acids steadily increased
over 24 h (Fig. S2) (9).
Activation states of GCN2 and mTORC1 were tracked by
assessing phosphorylation of their respective substrates, eIF2
and S6K1, respectively. Phosphorylation of eIF2 was increased
within 15 min after injection and reached a maximum by 30
min (Fig. 1B), which corresponded with the nadir in circulating
glutamine (Fig. S1). During this time frame, no significant
Figure1.Gcn2statusdetermines thehepatic eIF2andmTORC1response
to asparaginase (ASNase).A, schematic diagramof experimental setup. The
mice were injected intraperitoneally (IP) with ASNase and killed at regular
intervals over 24 h. Liver samples were analyzed for phosphorylation of eIF2
(p-eIF2) and p-S6K1. B, upper panels show representative immunoblots dis-
playing p-eIF2 at serine 51 and eIF2 total protein. Quantitative analysis of
individual values for p-eIF2 levels normalized to total eIF2 at each timepoint
is summarized in the bar graph in the lower panel. C, upper panels show rep-
resentative immunoblots displaying p-S6K1 at threonine 389 and total levels
of S6K1. Quantitative analysis of the Thr(P)-389 band intensities at each time
point is summarized in the bar graph in the lower panel. Fig. S3 shows images
of additional biological replicates. In B and C, circles represent individual liver
samples, and bars represent average values across the treatment groups 
S.D. *, significantly higher than values at 0 which are PBS-treated, p 0.05 by
t test; †, significantly lower than values at 0which are PBS-treated,p 0.05 by
t test.
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change inmTORC1activitywas evident in the livers ofwildtype
mice (Fig. 1C and Fig. S3). In contrast, strong activation of
mTORC1 was observed in the livers of Gcn2/ mice as evi-
denced by the rapid increase in S6K1 phosphorylation at Thr-
389 that lasted for at least 6 h (Fig. 1C and Fig. S3). Thus, Gcn2
deletion results in rapid and sustained activation of hepatic
mTORC1 in response to amino acid stress.
Hepatic Gcn2 status dictates the response of translational
machinery to amino acid stress
To assess the effect of amino acid depletion on gene-specific
translation in liver, we conducted polysome profile analysis at
multiple time points (Fig. 2A). Half an hour following asparag-
inase injection, we observed accumulation of 80S monosomes
in wildtype livers, but not in Gcn2/ livers (Fig. 2B), showing
that GCN2 is required for repression of mRNA translation ini-
tiation in response to amino acid depletion. This effect was
sustained for at least 3 h in wildtype mice, whereas in the livers
of Gcn2/ mice, little to no change in polysome profiles
occurred in the period of 30 min to 3 h following asparaginase
injection. Assessment of Atf4 mRNA distribution in polysome
profile fractions revealed accumulation of Atf4 mRNA in the
fractions heavily loaded with ribosomes as early as 1 h after
asparaginase exposure (Fig. 2C, left panel). Importantly,
Gcn2/ livers did not exhibit this shift in Atf4 mRNA distri-
bution (Fig. 2C, left panel). No apparent shift was found in the
control mRNA encoding for actin (Fig. 2C, right panel). Fig. S4
shows the analysis of additional polysome profiles. These data
indicate that 1) GCN2 kinase is required for translational
induction of Atf4 mRNA following amino acid depletion by
asparaginase, 2) gene-specific translation ofAtf4mRNAoccurs
very early following asparaginase injection, and 3) ATF4 syn-
thesis following a single injection of asparaginase is a transient
event, complete by 3 h after injection.
We proceeded to test whether hyperactivation of mTORC1
in Gcn2/ mice corresponded with maladaptive changes in
gene-specific translation, namely the enhanced translation of
TOP mRNAs (5). Quantitative analysis of the most responsive
TOP mRNAs (encoding ribosomal proteins Rps18 and Rps20
and Pabpc1 (poly(A)-binding protein cytoplasmic 1)) in poly-
somal fractions revealed their accumulation in heavy poly-
Figure 2. Loss of Gcn2 prevents increased Atf4mRNA translation efficiency in liver following ASNase exposure and instead permits enhanced TOP
tractmRNA translation.A, schematic diagramof polysomal profilingmethod. Polysomes from liver lysateswere separated based on their differentmigration
rates through sucrose gradients. Polysomal RNAwas isolated from fractions across the gradient, and translational efficiencywas assessed by RT-qPCR analysis
of RNA isolated from polysomal fractions. B, representative images of hepatic polysomal profiles from WT (left panel) and Gcn2/ (right panel) mice treated
withASNase. An increase in the80Speakheight inWT reflects inhibitionofmRNA translation initiationas early as 30minafter a single injectionof asparaginase.
This increase is not observed inGcn2/ following ASNase exposure. C, Atf4mRNA levels are present in heavier polysomes at 1 h after ASNase inWT but not in
Gcn2/mice. Black dotted lines of the polysomal profiles indicate the position of each fraction along the profile. The symbols represent values of relative Atf4
mRNA amount, expressed as a percentage of total mRNA value in all the fractions. D, assessment of select TOPmRNA (Rps18, Rps20, and Pabpc1) levels across
sucrosegradient fractions. Thepolysomal profile is shownbelow to indicate relativepositionof each fraction. The symbols represent values of relative amounts
of mRNAs in the collected fractions, expressed as percentages of total mRNA value in all the fractions.
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somes 1–3 h following asparaginase injection (Fig. 2D) in sam-
ples with the highest mTORC1 activity. Thus, altered TOP
mRNA translation is consequential to Gcn2 deletion during
amino acid stress.
We also assessed polysomal distribution of mRNAs that are
reportedly translationally enhanced in mouse livers upon per-
fusion with amethionine-deficient solution, namely chaperone
Hspa5 (heat shock protein family A5), amino acid transporter
Slc3a2 (solute carrier family 2 member 2), and transferrin
receptor Trf2 (transferring receptor 2; Ref. 22). None of these
mRNAs exhibited any changes in translational efficiency upon
asparaginase exposure (Fig. S5). This observation suggests that
hepatic response to amino acid stress by asparaginase is differ-
ent from the one caused by methionine deficiency. In fact,
recent studies demonstrate that hepatic responses to methio-
nine restriction are mediated in a eIF2 phosphorylation-inde-
pendent manner (23) and perhaps via its own unique pathway
(24).
Hyperactivation ofmTORC1 in Gcn2/ livers precedes
transcriptional control of mTORC1 repressors
To assess when ATF4 target genes serve as mTORC1 regu-
lators during amino acid stress, we examined mRNA levels of
Sesn2, 4ebp1,Trib3, andRedd1, as well as a few classic targets of
ATF4:Fgf21 (fibroblast growth factor 21),Asns (asparagine syn-
thetase), and Atf5. No acute changes were observed in hepatic
mRNA levels of any of the genes within the first hour following
injection. A robust increase inTrib3mRNAwas observed 3–18
h following asparaginase exposure in wildtype (up to 80 times
over untreated control) but not Gcn2/ livers. In the same
time frame,moderate elevationwas seen inRedd1mRNA levels
(up to 30 times), and only mild elevations in Sesn2 and 4ebp1
mRNAs (four times the maximum) were observed in wildtype,
but not in Gcn2/mice (Fig. 3). These data clearly show that
control of mTORC1 activity by known ATF4 targets occurs 3 h
or more following asparaginase exposure and thus cannot
explain the immediate loss of control over mTORC1 activity in
Gcn2/ livers.
Exposure to chemical ER stress does not activatemTORC1 in
livers lacking Perk
To checkwhether asparaginasemay acutely induce ER stress,
we analyzed PERK activation (Fig. 4A), which was assessed via
its phosphorylation at Thr-980. No activation of PERK was
observed in response to asparaginase exposure in either wild-
type or Gcn2/ livers (Fig. 4B), confirming that amino acid
depletion by asparaginase increases eIF2 phosphorylation via
GCN2 (25). Moreover, mice with genetic ablation of hepatic
Perk via Cre-mediated recombination (liver-specific Perk/,
ls-Perk/) displayed increased eIF2 phosphorylation and no
hyperactivation of mTORC1 in response to asparaginase expo-
sure, similar to wildtype animals (Fig. 4B).
To better understand whether communication between the
ISR and mTORC1 occurs more broadly in response to proteo-
toxic stress, we tested whether acute ER stress would cause
similar activation of mTORC1 in livers bearing genetically dis-
ruptedPerk (Fig. 4A). To test this idea, we injected tunicamycin,
a potent inhibitor of glycosylation and an ER stress–causing
agent, to wildtypemice,Gcn2/mice and ls-Perk/mice. As
expected, tunicamycin activated PERK, evidenced by its auto-
phosphorylation at Thr-980 (Fig. 4C). The response was very
similar in wildtype and Gcn2/ livers, whereas in ls-Perk/
mice, no phosphorylation of eIF2was evident (26). Remarkably,
no acute (over 90 min) activation of mTORC1 was observed in
the livers of anymouse strains following tunicamycin injection.
These data indicate that the type of cellular stress determines
whether or not a functional ISR–mTORC1 communication
axis exists.
Pretreatment of Gcn2/mice with tunicamycin rescues
hepatic mTORC1 repression following asparaginase exposure
We then tested whether induction of eIF2 phosphorylation
by alternative means inGcn2/mice would help prevent acti-
vation of mTORC1 (i.e. ISR preconditioning). To do this, wild-
type andGcn2/mice were injected with tunicamycin 30min
prior to asparaginase injection to induce phosphorylation of
eIF2 (Fig. 5A). Analysis of mTORC1 activity showed no hyper-
phosphorylation of S6K1 in the livers ofGcn2/mice precon-
ditionedwith tunicamycin (Fig. 5,B–D).However, genetic abla-
tion of bothPerk andGcn2/ in liver blocked phosphorylation
of eIF2 to both tunicamycin and asparaginase and allowed for
hyperactivation of mTORC1 once again (Fig. 5, B–D). These
data suggest that ISR preconditioning by another kinase is suf-
ficient to blockmTORC1 activation in response to acute amino
acid stress.
ISRIB reducesmTORC1 activity by itself yet fails to prevent
mTORC1 hyperactivation following asparaginase exposure in
Gcn2/ livers
Finally, to explore the relationship between eIF2B and
mTORC1 in response to asparaginase, we utilized the small
molecule inhibitor, ISRIB (Fig. 5E), which locks eIF2B in its
active dimer form and renders cells insensitive to eIF2 phos-
phorylation by PERK. To our surprise, administration of ISRIB
significantly reduced hepatic mTORC1 signaling independent
of GCN2 status (Fig. 5, F–I, compare bar graphs of control
versus ISRIB-treated animals). This noted decrease in
mTORC1 activity upon ISRIB exposure is consistent with the
published observation of ISRIB causing decreased translation
of TOP mRNAs (27). Nevertheless, administration of ISRIB 30
min prior to asparaginase did not affect mTORC1 activity in
wildtype mice, nor did it modify any measured outcome in
wildtype and Gcn2/ mice exposed to asparaginase (Fig. 5,
F–I). Considering ISRIB functions as an inhibitor of PERK sig-
naling, the results are consistentwith asparaginase treatment of
lsPerk/ mice and lsPerk/-Gcn2/ mice. Collectively,
these data show that it is the phosphorylation of eIF2 and not
ATF4 synthesis that directs mTORC1 regulation upon acute
amino acid stress.
Discussion
This study utilized chemical activators of the amino acid
response and the ER stress response to reveal new information
regarding a vital role for the GCN2-eIF2 axis in acutely regulat-
ing hepatic mTORC1 in mice. The data show that hyperactiva-
tion of hepatic mTORC1 inGcn2/mice exposed to asparag-
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inase occurs within minutes, preceding the timing of enhanced
translation of Atf4 mRNA and increased transcription of
mTORC1 inhibitors in wildtype mice. The inappropriately
high mTORC1 signaling in liver of Gcn2/mice corresponds
with movement of TOP mRNAs into polysomes, identifying
a physiologically maladaptive outcome resulting from
Figure 3. Time-resolved changes in hepatic expression of select ATF4 target genes after ASNase exposure. A, total RNAwas isolated from livers ofmice
after a single injection of ASNase and select ATF4 target genes were quantitatively assessed using RT-qPCR. B–H, Sesn2 (B), Redd1 (C), Asns (D), Trib3 (E), 4ebp1
(F), Fgf21 (G), and Atf5 (H). The boxes extend from the 25th to 75th percentiles as computed in GraphPad software using the following equation: r P * (n
1)/100, where P is the desired percentile, and n is the number of values in a data set.Whiskers extend to the maximum andminimum values of the data set. *,
significantly different as compared with values at 0, which represents PBS injection, p 0.05 by t test.
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enhanced mTORC1 signaling. Preconditioning the ISR in
Gcn2/ liver by activating PERK blocks mTORC1 activation
following amino acid depletion, which is reversed in the liver of
mice lacking both Gcn2 and Perk. Importantly, hepatic
mTORC1 activity is not unleashed by ER stress in ls-Perkmice,
signifying that communication between the ISR and mTORC1
is specific to sensing amino acid levels. Together these results
suggest that eIF2 phosphorylation is necessary to impart nega-
tive control of the ISR over mTORC1 during amino acid stress.
Rapid and robust activation of hepatic mTORC1 inGcn2/
mice given asparaginase supports a model wherein the GCN2-
eIF2 axis plays a suppressive, ATF4-independent role in regu-
lating mTORC1 activity upon sensing amino acid stress. This
suppressive role of GCN2 was first observed by us in mice fed a
leucine-devoid diet to Gcn2/mice (10), then confirmed and
further detailed using mice treated with asparaginase (8, 9, 19,
25). This work also strongly supports the findings of Averous et
al. (20), who used a model of leucine deprivation in mouse
Figure 4. Loss of Perk does not unleash mTORC1 signaling upon ASNase exposure or upon ER stress by tunicamycin (Tun). A, schematic diagram of
molecular cascades tested, namely the ISR andmTORC1pathwayafter a single injectionof eitherASNaseor Tun.B, p-S6K1at threonine389 is increased in livers
of Gcn2/ but not ls-Perk/mice. Two representative images are displayed next to mean values of band intensities for p-eIF2 and p-S6K1. v stands for PBS
vehicle control. Mean values combine results at 15, 30, and 60min after ASNase. C, no increase in p-S6K1 is noted in the livers of ls-Perk/mice injected with
Tun. Two representative images are displayed next to mean values of band intensities for p-eIF2 and p-S6K1. v stands for 0.3% DMSO vehicle control. Mean
values combine results at 30, 60, and 90min after a single injectionof Tun.Circles represent individual data points, andbars represent average values across the
treatment groups S.D. *, significantly higher than values at the corresponding v groups, p 0.05 by t test.
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embryonic fibroblasts (MEFs) to conclude that GCN2 and eIF2
phosphorylation, but not ATF4, are required for continuous
suppression of mTORC1 during leucine or arginine depriva-
tion. Deficiency in either of these two amino acids in Gcn2/
MEFs strongly activated mTORC1 within 15 min. In our
current and past in vivo models, we see hyperactivation of
Figure 5. Pretreatmentwith tunicamycin (Tun) rescues normal control ofmTORC1 by ASNase inGcn2/ livers, whereas ISRIB does not. A, schematic
diagramof the experiment.WT,Gcn2/, and ls-PERK/Gcn2/micewere injectedwith Tun 30min prior to ASNase, after which livers were collected at the
indicated timepoints.B, representative immunoblotsdisplayp-eIF2, p-S6K1, andp-PERK.C,meanvaluesofband intensities forp-eIF2 levels normalized to total
eIF2 at indicated time points. D, mean values of band intensities for p-S6K1 at threonine 389 at indicated time points. indicates positive control, which is
Gcn2/ liver collected 30min after ASNase; v represents vehicle control. Individual data points are shown in circles, and bars represent average values across
treatment groups S.D. *, p 0.05 by t test. E, schematic diagram of the experiment. WT and Gcn2/mice were administered ISRIB 30min prior to ASNase,
after which livers were collected at the indicated time points. F, representative immunoblots display p-eIF2 and p-S6K1 in WT and Gcn2/ livers. G, mean
values of band intensities for p-eIF2 levels normalized to total eIF2 protein. H, mean values of band intensities for p-S6K1 at threonine 389. I, mean values of
p-S6K1 at threonine 389 in both genetic strains combined (WT and Gcn2/) following a single injection of ISRIB alone. Individual data points are shown in
circles, and bars represent average values across treatment groups S.D. *, p 0.05 by t test as compared with vehicle treated control.
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mTORC1 within the first 30–60 min of amino acid depletion,
which is sustained for at least 6 h. Based on time-course results
by ourselves and others, we conclude that ATF4 is not neces-
sary to inhibit mTORC1 in response to amino acid deprivation.
Our work also expands on the findings of Ye et al. (16), report-
ing that GCN2 induces the expression of Sestrin2 to inhibit
mTORC1. No considerable induction of Sestrin2mRNA levels
was observed upon asparaginase exposure in our model of
amino acid deprivation. Considering that mTORC1 repression
can be rescued by ISR preconditioning via tunicamycin-in-
duced PERK, we conclude that eIF2 phosphorylation is
required for acute inhibition of mTORC1 upon amino acid
stress, in agreement with (20).
In our previous study of chronic exposure to asparaginase (8
days), obese Gcn2/ mice demonstrate PERK activation and
eIF2 phosphorylation alongside highly activated mTORC1 (8).
Thus, phosphorylation of eIF2 by PERK failed to prevent
mTORC1 activation in obese mice. We reconcile these results
by pointing out that the timing of PERK activation is very dif-
ferent in these two experimental models. In the current study,
PERK is activated before exposure to amino acid stress, allowing it
to functionasapreconditioningagent. In thepreviouswork,PERK
is not activated in the excipient-treatedmice, but only in asparagi-
nase-treatedmice, indicating that PERKbecomes engaged after or
in concert withGCN2. Overall, these data suggest that phosphor-
ylation of eIF2 is necessary but not sufficient to coordinate
mTORC1 signaling upon amino acid stress, and an intact GCN2-
eIF2 axis is a vital necessity in this regard.
As part of the ISR to amino acid stress, ATF4-mediated
induction of several mTORC1 inhibitors, namely Redd1 (28),
Trib3 (29), Sesn2 (16), and 4ebp1 (30), is reported as playing a
regulatory role.Our data show that of these four candidates, the
most robust induction was observed in the expression of Trib3
gene, coding for a negative regulator of insulin signaling (31),
whereas hepatic levels of Redd1, Sesn2, and 4ebp1 mRNAs
showed only modest increases, if any. In all cases, these
increases in mRNA levels were observed no earlier than 3 h
following the injection of asparaginase, again confirming that
acute inhibition of mTORC1 does not involve an ATF4-driven
transcriptional program. Interestingly, our previous studies
show that induction of Trib3 mRNA by asparaginase requires
GCN2, but not ATF4, because Atf4/ animals treated with
asparaginase demonstrate 10-fold greater increases in Trib3
mRNA levels to asparaginase than wildtype animals, whereas
no induction whatsoever is observed in Gcn2/ animals (8,
32). This confirms that the Trib3 gene is controlled by other
transcriptional factors in addition to ATF4 (18), but whether
TRIB3 represents the major effector of GCN2 pathway that
contributes to sustained inhibition of hepaticmTORC1 inWT,
as well as in Atf4/ animals, requires further investigation.
ATF4 is the central transcription factor of the ISR, but it is
also utilized by the mTORC1 pathway to support anabolic pro-
cesses (14, 15). For instance, stimulation ofmTORC1with insu-
lin in MEFs leads to the enhanced synthesis of ATF4 without
eIF2 phosphorylation. This increase in ATF4 can be blocked by
either cycloheximide, an inhibitor of protein synthesis, or rapa-
mycin (inhibitor of mTORC1), suggesting that both protein
synthesis andmTORC1 signaling are required for the increased
ATF4 protein levels (14). The proposed function of such signal-
ing cascade is to increase cellular uptake of essential amino
acids increase the synthesis of the non-essential ones (15),
thereby supporting anabolic reactions during insulin stimula-
tion of mTORC1. Our data demonstrate that hyperactive
mTORC1 per se is not a sufficient signal to induce enhanced
synthesis of ATF4 because we observed no translational induc-
tion of ATF4 in Gcn2/ animals with high mTORC1 activity.
The fact that the fundamentally distinct stimuli—insulin versus
acute amino acid stress in the background of systemic Gcn2
disruption—produce one outcome in the form of hyperactive
mTORC1 but distinct downstream response in the form of
ATF4 production implies the existence of yet-to-be-identified
factors, other than mTORC1, that influence cellular decision
whether to up-regulate synthesis of ATF4.
Deregulation of mTORC1 is associated withmany patholog-
ical conditions in the liver (11, 33, 34). Our study identifies
GCN2 and its downstream effector eIF2 as essential compo-
nents that coordinate hepatic mTORC1 during amino acid
stress. These data complement and providemechanistic insight
as to why maladaptive activation of hepatic mTORC1 in
Gcn2/mice associates with greater morbidity andmetabolic
toxicity (8) and have important implications for the clinical use
of rapidly growing class of GCN2-activating drugs (35–44).
Gcn2 is not an essential gene and so far is found to have 594
missense, 28 nonsense, and 33 frame-shifting mutations in the
human population (45). Our study found that GCN2 governs
important nutritional responses and, if dysfunctional, leads to
altered whole bodymetabolism. It is tempting to speculate that
as a result of this altered metabolism, subjects bearing deleteri-
ousmutations in theGcn2 (EIF2AK4) gene have higher chances
of developing metabolic conditions later in life such as pulmo-
nary arterial hypertension (46). This work provides a founda-
tion for personalized approaches in usage of other GCN2-acti-
vating drugs as well as dietary approaches.
Experimental procedures
Animals
All animals received humane care according to the criteria
outlined in the Guide for the Care and use of Laboratory Ani-
mals prepared by the National Academy of Sciences (National
Institutes of Health publication 86-23 revised 1985) and
ARRIVE guidelines. Animal protocols were reviewed and
approved by the Rutgers Institutional Animal Care and Use
Committee. Adult (10–20 weeks old) male and femaleWT and
Gcn2/ mice on the C57Bl/6J genetic background (47) were
used.Mice with albumin Cre-mediated deletion of Perk in liver
(lsPerk/) were also used (48), and these mice were bred to
Gcn2/mice to create a double knockdown of Perk andGcn2 in
liver. All mice were bred at the Bartlett animal facility on the Rut-
gers University Cook campus. All mice had free access to food
(5001 laboratory rodent diet; LabDiet) and water and maintained
on a 12-h light-dark cycle (7 a.m. to 7 p.m.) with same-sex litter-
mates until experimental group assignment, wherein mice were
housed in individual plastic cages with soft bedding.
Animals were administered a single injection of either bacte-
rial asparaginase (3 IU/g body weight; Elspar, Merck), tunica-
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mycin (1 mg/kg body weight; Sigma catalog no. T7765), or
ISRIB (0.25 mg/kg; Sigma catalog no. SML0843) and eutha-
nized by decapitation at indicated time points. The control
groups were treated with PBS (vehicle for asparaginase) or 0.3%
DMSO in PBS (vehicle for tunicamycin and ISRIB). All mice
were killed between 12 and 4 p.m. (ZT5-9).
Serum amino acid profiling
Trunk blood was collected into microcentrifuge tubes. Serum
wascollectedbycentrifugationafterbloodclottingon ice.Proteins
of the serum were precipitated by the addition of 180 l of a sol-
vent (0.1% formic acid inmethanol) to 60l of serum. The result-
ing cloudymixturewas filtered usingCaptiva non-drip lipid filtra-
tion tubes (Agilent catalog no. A5400635). The recovered clear
eluate in the amount of 20 l was spiked with 5 l of internal
standard (equimolarmix of sarcosine and norvaline, 0.1mM each)
and analyzed using reversed-phase high pressure liquid chroma-
tography (Agilent 1200HPLC instrument) according to theman-
ufacturer’s protocol (Agilent publication catalog no. 5990-
4547EN). Briefly, amino acid separation was carried out using a
gradient mix of mobile phase A (10 mM Na2HPO4, 10 mM
Na2B4O7, 5 mM NaN3, pH 8.2) and mobile phase B (acetonitrile/
methanol/water  45/45/10) on ZORBAX eclipse Plus C18 col-
umn at the speed of 0.42 ml/min. To allow for amino acid detec-
tion by fluorescence, derivatization was done automatically using
autosampler according to themanufacturer’s protocolmentioned
above and consisted of two consequent steps: 1) conjugation to
o-phthalaldehyde and 2) conjugation to fluorenylmethyloxycar-
bonyl chloride.Standardcurves foreachaminoacidwereretrieved
from analyzing a set of equimolar standardmixtures. A total of 10
standardmixtures were used ranging from 2.25 to 900M of each
amino acid. Analysis of chromatograms was performed using
Agilent OpenLAB software.
Immunoblotting
Liver tissue was crushed using the Cellcrusher tissue pulverizer
under liquid nitrogen conditions. The resulting tissue powderwas
lysedwith radioimmuneprecipitationassaybuffer (25mMHEPES,
pH 7.5, 10 mM DTT, 0.1% SDS, 1 protease inhibitor mixture
(Sigma; P8340), 1 mM sodium orthovanadate, 0.5% deoxycholate,
50 mM -glycerophosphate, 2 mM EDTA, 1 mM microcystin, 50
mM NaF, 3 mM benzamidine) using the Polytron bench top
homogenizer followed by heating the lysates for 5min in Laemmli
buffer. Primary antibodies usedwere as follows: anti-total p70S6K
(Cell Signaling Technology, CST 9202), anti-phospho-(Thr-389)-
S6K (Cell SignalingTechnology, CST 9205), and anti-eIF4E-bind-
ing protein 1 (Bethyl Laboratories A300-501A), anti-phos-
pho(S51)-eIF2 (Cell Signaling Technology, CST 3597), anti-eIF2
(Santa Cruz, sc-11386), anti-phospho(T980)-PERK (Santa Cruz,
sc-3179S), and anti-PERK (SantaCruz, sc-3192S). Secondary anti-
bodywasperoxidase-AffiniPure goat anti-rabbitTgC (HL) from
Jackson ImmunoResearch (111-035-003). The images were taken
with Fluorchem M imager (ProteinSimple), and band densities
were quantified using View software.
RT-qPCR
RNA was isolated from 10 mg of frozen tissue powder using
TRI reagent according to the manufacturer instructions.
Quality of the isolated RNA was assessed by measuring
A260/280 and A260/230 ratios; integrity was assessed by visualiza-
tion of the rRNA on agarose gels. One microgram of the iso-
lated RNA from each sample was used to generate cDNA using
high-capacity cDNA reverse transcription kit (Thermo Fisher
catalog no. 4368814). The resulting cDNA was used for quan-
titative analysis of gene expression using SYBR green system.
Validated primers sequences are listed in the supporting
information.
Polysomal profiling and RT-qPCR from sucrose gradients
Frozenmouse livers were crushed at liquid nitrogen temper-
ature with tissue pulverizer. Approximately 50mg of the frozen
tissue powder were homogenized using blue plastic pestles in
standard 1.5-ml microcentrifuge tubes using with lysis buffer
(25 mM HEPES-KOH, pH 7.5, 100 mM KCl, 5 mM MgCl2, 0.5%
deoxycholate, 1%Nonidet P-40, 1mMDTT, 1 protease inhib-
itor (Sigma catalog no. P8340), SUPERase-In RNase inhibitor
(Thermo Fisher catalog no. AM2696); tissue-to-lysis buffer
ratio was 1:10. The lysates were incubated on ice for 5 min and
centrifuged at 10,000 g for 10 min to get rid of nuclei and cell
debris. The cleared supernatants were loaded on 10–50%
sucrose gradients and centrifuged at 100,000  g for 3 h to
resolve mRNA species loaded with different amounts of ribo-
somes. The resolved polysomeswere collected in either 10 or 30
fractions from which RNA was isolated using TRI reagent for
liquid samples according to the manufacturer’s protocol. The
RNA precipitates were washed twice with 75% ethanol and
resuspended in 20 l of nuclease-free water. Quality of the iso-
lated RNA was assessed by measuring A260/280 and A260/230
ratios; integrity was assessed by visualization of the rRNA on
agarose gels. RT-qPCR was performed as described above with
the exception that the relative values of polysomal Atf4mRNA
were normalized to exogenous spike-in Luciferase instead of
glyceraldehyde-3-phosphate dehydrogenase.
Statistics
In most graphical displays, liver samples from animal sub-
jects are plotted individually alongside the mean values S.D.
or plotted as box-whisker plots where boxes extend from the
25th to 75th percentiles and whiskers extend to the maximum
and minimum values of the data set. Two group comparisons
were analyzed by t test assuming two-tailed distribution with
unequal variance and with an  level of p  0.05 (GraphPad
Prism, La Jolla, CA). A table listing the number of replicatemice
in each strain and treatment group is included in Table S1.
Additional details on experimental materials and procedures
are available in the supporting information.
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